ASHG Annual Meeting 2024

Join us in Denver, Colorado, from November 5 – 9, to learn about our latest advancements in sequencing, informatics, array and library prep solutions. From advancements on our NovaSeq X and NextSeq 1000/2000 workflows to microarray systems and informatic solutions, Illumina offers the tools that fit the complex needs of researchers across the genomic spectrum. From scalable single -omic to multi-omic solutions, come learn how Illumina can partner with you in advancing your genetics and genomic research.

Visit Illumina booth 503 at ASHG 2024, and attend our industry education session and co-labs to hear more about our products, workflow solutions, and partnerships.

Wednesday, November 6

Industry Education sessions

Illumina Innovation Roadmap
12 PM–1 PM (MT)
Rooms 109/111/113

Join us to hear from Steve Barnard about the latest Illumina innovations from library prep, sequencing, and analysis and learn how we are enabling transformative applications using multiomics. Niall Lennon, PhD from the Broad Institute of MIT will join Steve to provide insights into new Illumina technology.

Steve Barnard, PhD
Chief Technology Officer
Illumina

 

Niall Lennon, PhD
Chair and Chief Scientific Officer
Broad Clinical Labs, MIT

Thursday, November 7

CoLab

Evaluation of Circulating Protein Biomarkers for Cancer Detection Using Illumina Protein Prep Platform
9:45 AM - 10:15 AM (MT)
CoLab Theater 2

Join us to hear Krishna Morampudi, Associate Director of Product Management at Illumina, provide an overview of the Illumina Protein Prep product and workflow. Dr. Kamel Lahouel, PhD at TGen will also present on a new pilot study using the Illumina Protein Prep assay to investigate the potential of circulating protein concentrations as biomarkers for cancer detection.

Krishna Morampudi
Associate Director of Product Management
Illumina

Kamel Lahouel, PhD
Assistant Professor
The Translational Genomics Research Institute

Industry Education sessions

Characterization of Epigenetic Biomarkers to Better Understand Human Disease Risk
3 PM–4 PM (MT)
Room 105

We will highlight studies focused on the characterization of epigenetic biomarkers associated with disease and how these can be used to understand the impact of lifetime exposures on disease risk. This will be followed by an update on the Illumina Infinium Beadchip Roadmap.

Andres Cardenas, PhD, MPH
Assistant Professor, Department of Epidemiology & Population Health
Stanford University

John Picuri
Director, Global Head of Array Commercial
Illumina

Friday, November 8

Industry Education sessions

Power end-to-end workflows, multiomic solutions, and population insights with an integrated software ecosystem
12 PM–1 PM (MT)
Room 103

Join leaders from Illumina and the industry to learn how they are driving innovation in precision medicine, multiomics discovery, and population genomics with cutting edge software informatics solutions. We will explore how an integrated data ecosystem from sample management through interpretation helps them get to results they can trust, faster.

Melissa A Kelly, PhD, HCLD/CC(ABB)
Clinical Lab Director
The Jackson Laboratory's Advanced Precision Medicine Laboratory

 

Luigi Mancinelli
Senior Postdoctoral Associate
University of Pittsburgh

 

Rami Mehio
Head of Global Software & Informatics
Illumina